Dr. Thomas S. Higgins JR., MD
ENT (Otolaryngology) (Otolaryngology Physician)
- Medicare participating
At a glance
- Medical school
- University of Louisville School of Medicine (2006)
- Years since graduation
- 20
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 301
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Medical school: University of Louisville School of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Otolaryngology Physician primary
KY license TP529
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Norton Hospitals, Inc Louisville, KY
Medical groups
- Ent Care Centers PLLC (11 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 301
- Services billed
- 5,374
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Professional service for preparation and provision of 1 or more antigens | 1,350 | 71 |
| Established patient office or other outpatient visit, 30-39 minutes | 585 | 241 |
| Diagnostic exam of nasal passages using an endoscope | 583 | 256 |
| Test for allergy using allergenic extract injected into skin | 480 | 12 |
| Test for allergy using allergenic extract | 468 | 12 |
| Professional service for single injection of allergen | 376 | 37 |
| Professional service for multiple injections of allergen | 163 | 26 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 110 | 54 |
| Established patient office or other outpatient visit, 20-29 minutes | 91 | 84 |
| New patient office or other outpatient visit, 45-59 minutes | 60 | 60 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Fluticasone Propionate Other prescribers in Louisville, KY | 137 |
| Prednisone Other prescribers in Louisville, KY | 113 |
| Azelastine Hcl Other prescribers in Louisville, KY | 102 |
| Doxycycline Hyclate Other prescribers in Louisville, KY | 80 |
| Ipratropium Bromide Other prescribers in Louisville, KY | 65 |
| Cefuroxime (cefuroxime axetil) Other prescribers in Louisville, KY | 48 |
| Amoxicillin-Clavulanate Potass (amoxicillin/potassium clav) Other prescribers in Louisville, KY | 46 |
| Pantoprazole Sodium Other prescribers in Louisville, KY | 35 |
| Ondansetron Odt (ondansetron) Other prescribers in Louisville, KY | 34 |
| Omeprazole Other prescribers in Louisville, KY | 31 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 17 companies reported 84 payments worth $34,321 in total to this clinician.
| Genzyme Corporation | $13,150 |
|---|---|
| Regeneron Healthcare Solutions, Inc. | $11,290 |
| AstraZeneca Pharmaceuticals LP | $5,986 |
| Medtronic, Inc. | $2,254 |
| 3-d Matrix, Inc. | $474 |
| GlaxoSmithKline, LLC. | $461 |
| Aerin Medical Inc. | $322 |
| Optinose US, Inc. | $87.83 |
| Compensation for services other than consulting (speaking, faculty) | $27,266 |
|---|---|
| Travel and Lodging | $3,532 |
| Food and Beverage | $3,523 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Feb 20, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT; DUPIXENT · Immunology | $9,849 |
| Regeneron Healthcare Solutions, Inc. Jul 18, 2025 | Compensation for services other than consulting (speaking, faculty) | $7,973 |
| AstraZeneca Pharmaceuticals LP Dec 1, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,300 |
| Genzyme Corporation Feb 20, 2025 | Travel and Lodging DUPIXENT; DUPIXENT · Immunology · travel to Bath, OH · in-kind | $1,963 |
| Medtronic, Inc. Oct 10, 2025 | Compensation for services other than consulting (speaking, faculty) PROPEL · Otolaryngology (Ear, Nose, Throat) | $1,880 |
| Regeneron Healthcare Solutions, Inc. Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,876 |
| Genzyme Corporation Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $938 |
| Regeneron Healthcare Solutions, Inc. Jul 16, 2025 | Travel and Lodging travel to INDIANAPOLIS, IN · in-kind | $696 |
| AstraZeneca Pharmaceuticals LP Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $450 |
| Regeneron Healthcare Solutions, Inc. Jul 3, 2025 | Travel and Lodging travel to INDIANAPOLIS, IN · in-kind | $385 |
All 13 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $938 |
| AstraZeneca Pharmaceuticals LP Dec 1, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,300 |
| Medtronic, Inc. Oct 10, 2025 | Compensation for services other than consulting (speaking, faculty) PROPEL · Otolaryngology (Ear, Nose, Throat) | $1,880 |
| AstraZeneca Pharmaceuticals LP Oct 10, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Indianapolis, IN · in-kind Company’s descriptionSpeaker Expenses | $345 |
| AstraZeneca Pharmaceuticals LP Oct 10, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Indianapolis, IN · in-kind Company’s descriptionSpeaker Expenses | $72.00 |
| AstraZeneca Pharmaceuticals LP Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $450 |
| Regeneron Healthcare Solutions, Inc. Jul 18, 2025 | Compensation for services other than consulting (speaking, faculty) | $7,973 |
| Regeneron Healthcare Solutions, Inc. Jul 16, 2025 | Travel and Lodging travel to INDIANAPOLIS, IN · in-kind | $696 |
| Regeneron Healthcare Solutions, Inc. Jul 3, 2025 | Travel and Lodging travel to INDIANAPOLIS, IN · in-kind | $385 |
| Regeneron Healthcare Solutions, Inc. Jul 3, 2025 | Travel and Lodging travel to INDIANAPOLIS, IN · in-kind | $71.55 |
| Regeneron Healthcare Solutions, Inc. Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,876 |
| Genzyme Corporation Feb 20, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT; DUPIXENT · Immunology | $9,849 |
| Genzyme Corporation Feb 20, 2025 | Travel and Lodging DUPIXENT; DUPIXENT · Immunology · travel to Bath, OH · in-kind | $1,963 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $194,751 in research payments for these studies, mostly to the institutions running them.
- EFS of Bioabsorbable Implant for NSD
Spirair, Inc. · Completed · NCT05967169 - CTP 1563 COMPAER
Aerin Medical Inc. - CTP 2144 - DUO
Aerin Medical Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.